APC Ltd and VLE Therapeutics have achieved a positive independent verification opinion from EcoVerify for their 2025 greenhouse gas inventory, providing stakeholders with credible, evidence-based assurance over the organisations’ reported emissions.
About APC Ltd and VLE Therapeutics
APC is a pharmaceutical process-development company focused on accelerating the delivery of medicines through advanced science, engineering and digital technologies. Its Dublin facility brings together laboratory-based pharmaceutical research, process development and office operations. APC describes its purpose as advancing medicines through superior science and operates a 60,000-square-foot process-development facility equipped for synthetic and biologic development.
VLE Therapeutics is APC’s sister company and a science-first GMP manufacturing organisation supporting advanced therapies. Its capabilities include gene therapies, vaccines and advanced biologics, providing a bridge between process development and clinical manufacturing.
Together, APC and VLE form an integrated medicine-acceleration model designed to reduce development risk and help critical therapies reach patients faster.
The achievement
EcoVerify assessed APC Ltd and VLE Therapeutics’ organisational GHG inventory for the period 1 January to 31 December 2025. The verification covered:
- Scope 1 direct emissions
- Scope 2 emissions from imported electricity
- Significant Scope 3 emissions, including purchased goods and services, capital goods, energy-related activities, transportation, waste, business travel, employee commuting and upstream leased assets.
EcoVerify concluded, at a reasonable level of assurance, that the reported Scope 1, Scope 2 and Scope 3 emissions were material, complete and correctly declared. The verified inventory recorded total emissions of 2,063.512 tCO₂e, reported as 2,064 tCO₂e in the opinion summary.
The verification was conducted against the GHG Protocol Corporate Accounting and Reporting Standard, the GHG Protocol Corporate Value Chain (Scope 3) Standard and the EcoVerify GHG Programme, using ISO 14064-3 as the verification framework. The resulting positive opinion, certificate and verification mark were issued on the 25th June 2026.
Building confidence in sustainability reporting
“Achieving reasonable assurance for our GHG inventory was a significant milestone for APC Ltd and VLE Therapeutics, strengthening our transparency and demonstrating our ongoing commitment to sustainability. Reaching this milestone was made possible through the dedication of our team and EcoVerify’s rigorous verification process. Throughout our GHG verification journey, EcoVerify provided exceptional professionalism, technical expertise, and support, making the process efficient, collaborative, and straightforward. We greatly value their guidance and would confidently recommend EcoVerify to any organisation seeking a credible and reliable GHG verification partner.”
— Claire Cagney, EHS & Sustainability Lead
“Independent verification gives our customers, employees and partners greater confidence in the environmental information we report. This achievement reflects the commitment of colleagues across APC and VLE to improving how we measure, understand and manage our environmental impact. It also supports our vision to become the greenest, most sustainable Irish Pharma company.”
— Paul McCabe, Group Chief Operating Officer and Board Member, APC & VLE Therapeutics

Paul McCabe, Group Chief Operating Officer and Board Member, APC & VLE Therapeutics, Claire Cagney, Environment, Health, Safety and Sustainability Lead, APC & VLE Therapeutics, Jyotika Gupta, Sustainability Officer, APC Ltd and VLE Therapeutics, Manuel Gonzalez, Managing Director, EcoVerify, Kevin Traynor, BeGreen@Cherrywood Chair, APC Ltd and VLE Therapeutics, Tom Bolger, BeGreen@Cherrywood Member, APC Ltd and VLE Therapeutics and Helen Budowsky, Lead Verifier and Quality Manager, EcoVerify. Special thanks to Elizabeth Rush, Accounts Payable Lead, APC Ltd and VLE Therapeutics, not pictured.
Independent assurance from EcoVerify
EcoVerify is an Irish sustainability assurance body specialising in the independent validation and verification of carbon footprints, GHG inventories, carbon-neutrality claims and Net Zero Pathways. Its services help organisations replace unsupported environmental claims with transparent, independently assessed evidence.
EcoVerify operates with accreditation from the Dutch Accreditation Council, Raad voor Accreditatie, under internationally recognised validation and verification requirements. In April 2025, EcoVerify became the first organisation worldwide accredited to verify carbon-neutrality claims under ISO 14068-1 and to validate and verify Net Zero Pathways.
“APC and VLE have demonstrated strong leadership by subjecting their complete organisational GHG inventory to reasonable-assurance verification. Their team approached the process with openness, professionalism and a clear commitment to data quality. This positive opinion provides a credible foundation for future emissions management and transparent sustainability communication.”
— Manuel Gonzalez, Managing Director, EcoVerify
By independently verifying their 2025 inventory, APC Ltd and VLE Therapeutics have established a robust baseline for tracking performance, identifying emissions hotspots and supporting credible future climate action.